http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101303088-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-661 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 |
| filingDate | 2009-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101303088-B1 |
| titleOfInvention | Injectable pharmaceutical composition containing 3- (hydroxymethyl) -5,5-diphenylhydantoin disodium phosphate ester |
| abstract | The present invention provides 35-180 mg / mL disodium phosphate ester of 3- (hydroxymethyl) -5,5-diphenylhydantoin in distilled water for injection; 0.02 to 0.04 M of at least one buffer selected from the group consisting of sodium carbonate, potassium chloride, and sodium citrate; And a pH adjuster in an amount necessary to adjust the pH of the composition to a pH in the range of 8.3 to 9.3. The pharmaceutical composition according to the present invention is an injectable solution containing a trace amount of a buffer and has very good storage stability.n n n 3- (hydroxymethyl) -5,5-diphenylhydantoin disodium phosphate ester |
| priorityDate | 2009-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.